Insomnia is highly prevalent in clinical populations as a primary or co-morbid disorder, and CBT-I is now considered the first-line treatment for insomnia. CBT-Iimproves sleep in 70-80% of patients, is more effective than sleeping pills, and reduces or eliminates sleeping pills in the vast majority of patients. It also doubles the remission rates of depression compared to antidepressant medication alone in depressed patients with insomnia, and it improves sleep and other comorbid medical and psychological symptoms in patients with insomnia (pain, PTSD, etc.). As a result, chronic insomnia is now considered an independent disorder that should be treated separately from co-morbid conditions.
Although CBT-I is now considered the first-line treatment for chronic insomnia due to its superior long-term efficacy, lack of side effects, and patient preference, there is a shortage of clinicians with expertise in CBT-I.
This workshop will enable clinicians to develop competence in CBT-I using an empirically and clinically validated CBT-I protocol. It is based on almost three decades of clinical practice and research at Harvard Medical School and the University of Massachusetts Memorial Medical Center involving over 10,000 insomnia patients and a landmark federally-funded study conducted at Harvard Medical School by Gregg D. Jacobs, Ph.D. and colleagues demonstrating that the same CBT-I protocol was more effective than Ambien (Jacobs, GD, et al. Cognitive Behavior Therapy and Pharmacotherapy for Insomnia: a Randomized Controlled Trial and Direct Comparison. Archives of Internal Medicine, 2004, 164: 1888-96).
The workshop includes a brief CBT-I training manual for clinicians.
- Empirical support for CBT-I
- Sleep and insomnia: basic concepts
- Sleep medications used to treat insomnia
- Assessment of insomnia patients
- Rationale for, and implementation of, CBT-I techniques including cognitive restructuring, sleep scheduling, stimulus control, relaxation, sleep hygiene, and sleep medication tapering and a sleep diary
- Sample case studies
Dr. Gregg D. Jacobs is a sleep psychologist and has spent thirty years researching and treating insomnia at the Harvard and University of Massachusetts Medical Schools. His insomnia research was funded by the National Institutes of Health and published in journals such as the Archives of Internal Medicine. He has taught his insomnia program to over 10,000 patients, to HMOs such as Kaiser Permanente and Fortune 500 companies such as Reebok, Fidelity, and John Hancock, and his insomnia program is used by major insurers such as Blue Cross and Blue Shield and Fortune 500 companies such as Raytheon. Dr. Jacobs is the author of “Say Good Night to Insomnia” (New York: Henry Holt) which has been translated into eight languages and has been described by the Wall Street Journal as a “pioneer in the use of cognitive-behavioral therapy for insomnia”.
PortlandThu, September 7, 2017 from 8:30am – 2:30pm
Italian Heritage Center
40 Westland Avenue
Portland, ME 04102
Register BangorFri, September 8, 2017 from 8:30am – 2:30pm
Spectacular Event Center
395 Griffin Road
Bangor, ME 04401